These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 9224476

  • 1. Multidisciplinary management of refractory orbital rhabdomyosarcoma.
    Mannor GE, Rose GE, Plowman PN, Kingston J, Wright JE, Vardy SJ.
    Ophthalmology; 1997 Jul; 104(7):1198-201. PubMed ID: 9224476
    [Abstract] [Full Text] [Related]

  • 2. Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience.
    Fiorillo A, Migliorati R, Grimaldi M, Vassallo P, Canale G, Tranfa F, Uccello G, Fiore M, Muto P, Menna G.
    Cancer; 1991 Feb 01; 67(3):560-3. PubMed ID: 1985749
    [Abstract] [Full Text] [Related]

  • 3. Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma.
    Zloto O, Minard-Colin V, Boutroux H, Brisse HJ, Levy C, Kolb F, Bolle S, Carton M, Helfre S, Orbach D.
    Acta Ophthalmol; 2021 May 01; 99(3):334-341. PubMed ID: 32833335
    [Abstract] [Full Text] [Related]

  • 4. [Rhabdomyosarcoma of the orbits in childhood].
    Humpl T, Brühl K, Pitz S, de Mooy P, Bartels U, Gutjahr P.
    Ophthalmologe; 1997 Dec 01; 94(12):914-9. PubMed ID: 9487763
    [Abstract] [Full Text] [Related]

  • 5. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
    Shields CL, Shields JA, Honavar SG, Demirci H.
    Ophthalmology; 2001 Dec 01; 108(12):2284-92. PubMed ID: 11733272
    [Abstract] [Full Text] [Related]

  • 6. Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.
    Eade E, Tumuluri K, Do H, Rowe N, Smith J.
    Clin Exp Ophthalmol; 2017 Mar 01; 45(2):168-173. PubMed ID: 27473389
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of orbital rhabdomyosarcoma (author's transl)].
    Jürgensen OA, Reinartz G, Pichler E.
    Padiatr Padol; 1982 Mar 01; 17(2):329-39. PubMed ID: 7099686
    [Abstract] [Full Text] [Related]

  • 8. Multidisciplinary collaborative therapy for 30 children with orbital rhabdomyosarcoma.
    Ge X, Huang DS, Shi JT, Ma JM.
    Asian Pac J Cancer Prev; 2013 Mar 01; 14(8):4641-6. PubMed ID: 24083717
    [Abstract] [Full Text] [Related]

  • 9. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
    Schoot RA, Saeed P, Freling NJ, Blank LE, Pieters BR, van der Grient JN, Strackee SD, Bras J, Caron HN, Merks JH, Amsterdam Head and Neck Working Group on Childhood Tumors.
    Ophthalmic Plast Reconstr Surg; 2016 Mar 01; 32(5):354-60. PubMed ID: 26398242
    [Abstract] [Full Text] [Related]

  • 10. Limits and chances in an unfortunate course of recurrent orbital rhabdomyosarcoma.
    Rustemeyer J, Günther L, Junker K.
    Nepal J Ophthalmol; 2011 Mar 01; 3(2):202-5. PubMed ID: 21876600
    [Abstract] [Full Text] [Related]

  • 11. Management of massive orbital involvement of intraocular retinoblastoma.
    Kiratli H, Bilgiç S, Ozerdem U.
    Ophthalmology; 1998 Feb 01; 105(2):322-6. PubMed ID: 9479294
    [Abstract] [Full Text] [Related]

  • 12. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.
    Strege RJ, Kovács G, Meyer JE, Holland D, Claviez A, Mehdorn MH, Interdisciplinary Group of Orbitazentrum UK S-H.
    Strahlenther Onkol; 2009 Dec 01; 185(12):789-98. PubMed ID: 20013088
    [Abstract] [Full Text] [Related]

  • 13. Prognosis of orbital rhabdomyosarcoma in children in Japan.
    Takahashi N, Minoda K.
    Jpn J Ophthalmol; 1991 Dec 01; 35(3):292-9. PubMed ID: 1770669
    [Abstract] [Full Text] [Related]

  • 14. Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee.
    Wharam M, Beltangady M, Hays D, Heyn R, Ragab A, Soule E, Tefft M, Maurer H.
    Ophthalmology; 1987 Mar 01; 94(3):251-4. PubMed ID: 3587902
    [Abstract] [Full Text] [Related]

  • 15. Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study.
    Heyn R, Ragab A, Raney RB, Ruymann F, Tefft M, Lawrence W, Soule E, Maurer HM.
    Cancer; 1986 May 01; 57(9):1738-43. PubMed ID: 3955518
    [Abstract] [Full Text] [Related]

  • 16. [Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
    Olivier Pascual N, Calvo JM, Abelairas Gómez JM.
    Arch Soc Esp Oftalmol; 2005 Jun 01; 80(6):331-8. PubMed ID: 15986273
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of the results of treatment orbital rhabdomyosarcoma in children].
    Chipczyńska B, Grałek M, Hautz W, Kanigowska K, Kocyła-Karczmarewicz B, Trzebicka A, Kepa B.
    Klin Oczna; 2007 Jun 01; 109(1-3):18-21. PubMed ID: 17687906
    [Abstract] [Full Text] [Related]

  • 18. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
    Gandhi PD, Fleming JC, Haik BG, Wilson MW.
    Ophthalmic Plast Reconstr Surg; 2011 Jun 01; 27(4):241-6. PubMed ID: 21242849
    [Abstract] [Full Text] [Related]

  • 19. [Update of orbital rhabdomyosarcoma therapy in children].
    Ducrey N, Nenadov-Beck M, Spahn B.
    J Fr Ophtalmol; 2002 Mar 01; 25(3):298-302. PubMed ID: 11941256
    [Abstract] [Full Text] [Related]

  • 20. Clinical Management of Orbital Rhabdomyosarcoma in a Referral Center in Spain.
    Bravo-Ljubetic L, Peralta-Calvo J, Larrañaga-Fragoso P, Pascual NO, Pastora-Salvador N, Gomez JA.
    J Pediatr Ophthalmol Strabismus; 2016 Mar 01; 53(2):119-26. PubMed ID: 27018885
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.